These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27557937)

  • 41. Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: a randomised, double-blind, placebo-controlled study in Spanish iron-deficient women.
    Blanco-Rojo R; Pérez-Granados AM; Toxqui L; González-Vizcayno C; Delgado MA; Vaquero MP
    Br J Nutr; 2011 Jun; 105(11):1652-9. PubMed ID: 21303569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. We Give Too Much Intravenous Iron.
    Dwyer JP
    Semin Dial; 2016 Jul; 29(4):309-11. PubMed ID: 27153768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers.
    Pawsey S; Wood M; Browne H; Donaldson K; Christie M; Warrington S
    Drugs R D; 2016 Jun; 16(2):181-91. PubMed ID: 26987975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
    Lasocki S; Piednoir P; Couffignal C; Rineau E; Dufour G; Lefebvre T; Puy H; Duval X; Driss F; Schilte C
    Crit Care Med; 2016 Mar; 44(3):521-30. PubMed ID: 26605680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.
    Perrine SP; Wargin WA; Boosalis MS; Wallis WJ; Case S; Keefer JR; Faller DV; Welch WC; Berenson RJ
    J Clin Pharmacol; 2011 Aug; 51(8):1186-94. PubMed ID: 21422239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Supplemental iron via dialysate: a novel mode of delivery for hemodialysis patients.
    Macdougall IC
    Kidney Int; 2015 Nov; 88(5):946-9. PubMed ID: 26579682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Low-Dose Ferric Citrate Is a Useful Iron Source for Hyperphosphatemic Hemodialysis Patients: A Case Series.
    Tanemoto M; Ishimoto Y; Saito H
    Blood Purif; 2017; 43(1-3):97-100. PubMed ID: 27951582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
    Warady BA; Zobrist RH; Wu J; Finan E;
    Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ferric pyrophosphate citrate: interactions with transferrin.
    Pratt R; Handelman GJ; Edwards TE; Gupta A
    Biometals; 2018 Dec; 31(6):1081-1089. PubMed ID: 30311019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
    Danielson BG; Salmonson T; Derendorf H; Geisser P
    Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study.
    Lainé F; Laviolle B; Bardou-Jacquet E; Fatih N; Jezequel C; Collet N; Ropert M; Morcet J; Hamon C; Reymann JM; Loréal O
    Fundam Clin Pharmacol; 2017 Oct; 31(5):567-573. PubMed ID: 28370178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status.
    Toblli JE; Di Gennaro F
    PLoS One; 2015; 10(4):e0125528. PubMed ID: 25928811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study.
    Xu H; Sheng L; Chen W; Yuan F; Yang M; Li H; Li X; Choi J; Zhao G; Hu T; Li Y; Zhang Y; Chen L
    Drug Des Devel Ther; 2016; 10():1619-26. PubMed ID: 27274195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
    Susantitaphong P; Alqahtani F; Jaber BL
    Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
    Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate.
    Cercamondi CI; Duchateau GS; Harika RK; van den Berg R; Murray P; Koppenol WP; Zeder C; Zimmermann MB; Moretti D
    Br J Nutr; 2016 Aug; 116(3):496-503. PubMed ID: 27267429
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.